-
公开(公告)号:US20230348385A1
公开(公告)日:2023-11-02
申请号:US18041682
申请日:2021-08-17
申请人: Biosynth AG
发明人: Rith CHEAV , Urs SPITZ , Christophe E.M. WEYMUTH
IPC分类号: C07D209/36
CPC分类号: C07D209/36 , C07B2200/13
摘要: Polymorphs of 5-bromo-6-chloro-3-indoxyl caprylate characterized by the powder diffraction patterns as defined in FIG. 1 and FIG. 2.
-
公开(公告)号:US20220251133A1
公开(公告)日:2022-08-11
申请号:US17711799
申请日:2022-04-01
申请人: Biosynth AG
发明人: Günter SCHABERT , Urs SPITZ , Aysel SOYDEMIR , Iris ZIMMERMANN
IPC分类号: C07H19/048 , C07H1/06
摘要: The present invention relates to a method of making nicotinamide ribofuranosie salts, in particular pharmaceutically acceptable nicotinamide ribofuranoside salts. The invention further relates to the nicotinamide ribofuranoside salts as such, in particular carboxylic acid salts in crystalline form, and their use in nutritional supplements and pharmaceutical compositions.
-
公开(公告)号:US20230110491A1
公开(公告)日:2023-04-13
申请号:US17908886
申请日:2021-03-08
申请人: Biosynth AG
发明人: Julian IHSSEN , Urs SPITZ
摘要: The present invention relates to a method for assessing cell viability of bacterial and fungal cells and to a method for the detection of bacterial and fungal cells with specific enzyme activities. The methods of the present invention rely on the real-time measurement of the level of luminescence signal from a luciferase enzyme directly from a growing culture of bacterial or fungal cells. Furthermore, the present invention relates to a method for assessing susceptibility of bacterial cells to antibiotics by measuring ATP levels using a luciferase assay system.
-
公开(公告)号:US20220135610A1
公开(公告)日:2022-05-05
申请号:US17576699
申请日:2022-01-14
申请人: Biosynth AG
发明人: Günter SCHABERT , Urs SPITZ , Aysel SOYDEMIR , Iris ZIMMERMANN
IPC分类号: C07H19/048 , C07H1/06
摘要: The present invention relates to a method of making nicotinamide ribofuranoside salts, in particular pharmaceutically acceptable nicotinamide ribofuranoside salts. The invention further relates to the nicotinamide ribofuranoside salts as such, in particular carboxylic acid salts in crystalline form, and their use in nutritional supplements and pharmaceutical compositions.
-
-
-